ArticleScientific reports2026
Morphomolecular characterization and statistical assessment of environmental associations with Diplectanum infestation in cultured European sea bass and bath treatment efficacy.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Monogenean infections are one of the most economically important parasitic constraints in marine aquaculture; however, knowledge remains limited regarding their genetic diversity, epidemiology, and sustainable management strategies. This study investigated the prevalence, morphomolecular characterization, environmental drivers, and eco-friendly control of naturally occurring monogenean infections in European sea bass (Dicentrarchus labrax) from two marine farms along the Egyptian Mediterranean coast between February and May 2024. Infected fish exhibited respiratory distress, skin darkening, anorexia, and progressive emaciation under heavy infestation. Examination of gill smears identified an elongate-oval monogenean exhibiting morphological features consistent with D. laubieri. Phylogenetic analysis of partial 18 S rRNA gene sequences placed the specimen within the Diplectanum clade, corroborating its taxonomic affiliation (GenBank accession no. PZ253293.1). Parasitological indices varied significantly between farms, with a higher prevalence recorded at Farm 2 (75.00 ± 6.87%) than at Farm 1 (65.56 ± 7.51%) (p < 0.05). Seasonally, the highest prevalence occurred in February, followed by a decline in April and a slight increase in May. Water quality analysis indicated a progressive rise in temperature on both farms, reaching 25.40 ± 0.16 °C in May. In contrast, Farm 2 was characterized by higher salinity, pH, and total ammonia levels, together with lower dissolved oxygen concentrations. Correlation analysis demonstrated a strong negative association between parasite prevalence and water temperature (r = - 0.736, p < 0.05), whereas no significant correlations were observed with salinity, pH, dissolved oxygen, or total ammonia. In trials of treating the affected fish and based on toxicity testing, the safe exposure threshold for Y. schidigera extract was established at 150-200 µg/L, while fenbendazole exhibited a safe exposure limit of 20 µg/L. The experimental cohabitation successfully reproduced the infection, achieving a prevalence of 90% by day 14. Comparative therapeutic efficacy trials demonstrated the superior performance of Y. schidigera relative to fenbendazole under the present study conditions, with parasite reduction rates of 80.4% and 68.5%, respectively, accompanied by a lower incidence of mortality. Collectively, these findings highlight the combined influence of environmental conditions on monogenean infection dynamics and support phytogenic-based Y. schidigera as a promising eco-friendly alternative for parasite control in marine aquaculture systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.